Skeletal muscle weakness caused by carrageenan-induced inflammation

Muscle Nerve. 2012 Sep;46(3):413-20. doi: 10.1002/mus.23318.

Abstract

Introduction: The skeletal muscle weakness associated with many chronic diseases has been attributed to the catabolic effect of pro-inflammatory cytokines. We aimed to determine if local muscle inflammation has direct affects on contractile function and contributes to muscle weakness independent of muscle atrophy or mechanical injury.

Methods: Local muscle inflammation was induced by injecting an algal-derived polysaccharide, carrageenan (10 mg/kg), into the right tibialis anterior muscle in healthy ARC mice. The contralateral muscle was injected with sterile isotonic saline, and the muscles were removed after 24 h for measurement of contractile function and cytokine concentration.

Results: Carrageenan significantly reduced maximum specific force, decreased the maximum rate of force development, altered the force-frequency relationship, and increased intramuscular levels of pro-inflammatory cytokines and chemokines.

Conclusions: These results indicate that carrageenan directly affects contractile function and causes skeletal muscle weakness. Local muscle inflammation may contribute to the weakness observed in inflammatory related disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carrageenan*
  • Cytokines / metabolism
  • Inflammation / chemically induced*
  • Inflammation / metabolism
  • Inflammation / physiopathology
  • Mice
  • Muscle Contraction / drug effects
  • Muscle Contraction / physiology
  • Muscle Weakness / chemically induced*
  • Muscle Weakness / metabolism
  • Muscle Weakness / physiopathology
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / physiopathology

Substances

  • Cytokines
  • Carrageenan